A new hormone therapy with drospirenone and NO production in postmenopausal women.
Tsuda
Kazushi
K
D000736:Androstenes / Q000627:therapeutic use*; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control; D004958:Estradiol / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D009569:Nitric Oxide / Q000096:biosynthesis* / Q000097:blood; D017698:Postmenopause / Q000097:blood* / Q000187:drug effects
D000736:Androstenes; D000959:Antihypertensive Agents; D000451:Mineralocorticoid Receptor Antagonists; D009569:Nitric Oxide; D004958:Estradiol; C035144:drospirenone